Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"Ataxia with Ocular Apraxia Type 1 (AOA1) (APTX, W279* Mutation): Neurological, Neuropsychological, and Molecular Outlining of a Heterogenous Phenotype in Four Colombian Siblings. Mol Neurobiol. 2022 Jun;59(6):3845-3858. Epub 2022"

Abril 14, 2022

Leer más

Neurología

"on behalf research priorities LACTRIMS Working Group. Research priorities in multiple sclerosis in Latin America: A multi- stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Mult Scler Relat Disord."

Mayo 24, 2021

Leer más

Neurología

"All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Yes. Mult Scler."

Mayo 2, 2022

Leer más